The Biden administration’s recent drug price negotiations under the Inflation Reduction Act re...
Read moreEffective pricing and market access (PMA) teams are vital for pharmaceutical companies to secure rei...
Read moreThe Saudi Food & Drug Authority (SFDA) released guidelines for Economic Evaluation Studies to assess...
Read moreIncrease in net spending and challenges in balancing healthcare budgets highlighted in AIFA's latest...
Read moreThe rise of personalised medicine is revolutionizing healthcare, prompting a re-evaluation of tradit...
Read moreScottish Medicines Consortium approves the use of obesity treatment under the NHS in UK first, whils...
Read moreThe German government’s proposal to keep negotiated confidential rebates was rejected by the feder...
Read moreSafety signals have sparked vital discussions on patient access to ATMPs, marking a pivotal moment i...
Read moreNew website provides regular updates on NLF's work, addresses challenges, and showcases collaboratio...
Read moreThe World Evidence, Pricing, and Access (EPA) Congress stands as Europe’s premier event in mar...
Read more